Bionomics Limited

ASX:BNO ISIN:AU000000BNO5

Bionomics (ASX:BNO, BNOOA; BNOOB, US OTC:BMICY) discovers and develops innovative therapeutics, working with partners to maximise wealth for shareholders. The Company leverages its proprietary platforms MultiCore, ionX and Angene to discover new treatments for CNS disorders, including anxiety and epilepsy, and cancer. 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 12314

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article

AUDIO: Bionomics Limited ASX: BNO - 2007 Annual General Meeting - Dr Peter Jonson, Chairman And Dr Deborah Rathjen, CEO And MD

🕔11/7/2007 11:17:00 AM 3110

Bionomics Limited (ASX: BNO) - 2007 Annual General Meeting - Dr Peter Jonson, Chairman and Dr Deborah Rathjen, CEO and MD; Bionomics Limited (ASX: BNO) present the following audio webcast regarding "2007 Annual General Meeting".

Read Full Article

Bionomics Limited ASX: BNO - Bionomics Raises $10 Million in Private Placement - Dr Deborah Rathjen, CEO and MD

🕔6/21/2007 1:26:00 PM 3030

Bionomics Limited (ASX: BNO) - Bionomics Raises $10 Million in Private Placement - Dr Deborah Rathjen, CEO and MD; Boardroomradio is pleased to announce that Bionomics Limited (ASX: BNO) has published an audio file.

Read Full Article

Bionomics Limited ASX: BNO - New Drug Candidate for Anxiety - Dr Deborah Rathjen, CEO and MD

🕔5/31/2007 1:40:00 PM 3035

Bionomics Limited (ASX: BNO) - New Drug Candidate for Anxiety - Dr Deborah Rathjen, CEO and MD; Boardroomradio is pleased to announce that Bionomics Limited (ASX: BNO) has published an audio file.

Read Full Article

Bionomics Limited ASX: BNO - Annual General Meeting - Dr Deborah Rathjen, CEO & MD

🕔11/9/2006 12:46:00 PM 3599

Bionomics Limited (ASX: BNO) - Annual General Meeting - Dr Deborah Rathjen, CEO & MD; Boardroomradio is pleased to announce that Bionomics Limited (ASX: BNO) has published an audio file.

Read Full Article

Bionomics Limited ASX: BNO - Contract with SAFC Pharma - Dr Deborah Rathjen, CEO & MD

🕔10/25/2006 2:43:00 PM 3697

Bionomics Limited (ASX: BNO) - Contract with SAFC Pharma - Dr Deborah Rathjen, CEO & MD; Boardroomradio is pleased to announce that Bionomics Limited (ASX: BNO) has published an audio file.

Read Full Article

BIONOMICS LIMITED ASX: BNO - The New Bionomics - Dr Deborah Rathjen, CEO

🕔6/27/2006 9:37:00 AM 2877

BIONOMICS LIMITED (ASX: BNO) - The New Bionomics - Dr Deborah Rathjen, CEO; Boardroomradio is pleased to announce that BIONOMICS LIMITED (ASX: BNO) has published an audio file.

Read Full Article

BIONOMICS LIMITED ASX: BNO - Market Briefing - Dr Deborah Rathjen, CEO

🕔4/28/2006 2:00:00 PM 3035

BIONOMICS LIMITED (ASX: BNO) - Market Briefing - Dr Deborah Rathjen, CEO; Boardroomradio is pleased to announce that BIONOMICS LIMITED (ASX: BNO) has published an audio file. The following presentatio

Read Full Article

Bionomics Granted Patent for Anti-Cancer Compounds

🕔11/1/2005 1:10:26 PM 2139

Bionomics (ASX:BNO, BNOOA, BNOOB, US OTC:BMICY) today announced that it has been granted a patent in New Zealand for a series of compounds that have shown promise as potential new treatments for cancer.

Read Full Article
###

3,900 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 7) (Last 30 Days: 30) (Since Published: 3900) 

Company Data

    Fax
  • 08 8354 6199 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 1999/12/21 
  • Homepage
  • www.bionomics.com.au/
  • E:
  • investorrelations@bionomics.com.au